• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Higher BMI Linked to Poorer Sexual Function in Postmenopausal Women, but Pooled Evidence Remains Weak

by
October 28, 2026
in Health
Reading Time: 3 mins read
0
Higher BMI Linked to Poorer Sexual Function in Postmenopausal Women, but Pooled Evidence Remains Weak

Higher BMI Linked to Poorer Sexual Function in Postmenopausal Women, but Pooled Evidence Remains Weak

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Higher body mass index is frequently associated with reduced sexual function in postmenopausal women, but the pooled statistical evidence does not yet support a firm conclusion, according to a systematic review and meta-analysis published in the European Journal of Medical Research. The review found that most of the included studies reported a statistically significant inverse association between BMI and sexual function, yet a meta-analysis of a small subset of studies showed no significant pooled effect.

The research team, led by Soheila Nazarpour with colleagues Masoumeh Simbar, Zahra Kiani and Reza Taherian, set out to clarify a question of growing public health relevance. Female sexual dysfunction is described in the paper as a common and multifactorial problem in postmenopausal women that affects quality of life. With obesity rates rising worldwide, the authors considered body mass index a potential contributing factor worth examining systematically.

The review followed PRISMA guidelines. The researchers searched international databases including PubMed, Scopus, Web of Science, ScienceDirect, Embase and the Cochrane Library, along with Iranian databases such as IranMedex, Magiran, IranDoc and SID, with the search covering literature up to August 2026. They included observational studies of cross-sectional, cohort and case-control design that examined the association between BMI and sexual function in postmenopausal women, applying no restrictions on language or publication date.

Study quality was assessed with the Joanna Briggs Institute checklists. For the quantitative synthesis, the team used a random-effects model with restricted maximum likelihood estimation. Between-study heterogeneity was evaluated with Cochran’s Q test and the I2 statistic, and publication bias was assessed using Egger’s regression test.

After an updated search, 25 studies met the eligibility criteria and entered the qualitative synthesis. Thirteen of these studies, or 52 percent, enrolled exclusively postmenopausal women, while the remainder included mixed menopausal populations. The studies were conducted across 14 different countries between 1996 and 2026, spanning three decades of research on the topic.

The main instrument for assessing sexual function was the Female Sexual Function Index, used in ten of the studies. The remaining studies relied on other measures, including the Cervantes scale, the MHR-QOL, the McCoy scale, the CSFQ-14, the Sexual Activity Questionnaire, the Modified Kupperman Menopausal Index, or questionnaires designed by the researchers themselves.

The systematic review of the 25 studies showed mixed findings across the included studies, with most reporting an inverse association between BMI and sexual function. Nineteen studies, or 76 percent, reported a statistically significant inverse association between BMI and sexual function, with the effect appearing particularly in the domains of satisfaction, desire and arousal. However, three studies, or 12 percent, found no significant relationship, and another three studies, also 12 percent, reported a positive relationship between BMI and sexual function, underscoring the inconsistency in the literature.

The meta-analysis told a more cautious story. Pooling four studies that allowed a quantitative estimate, the researchers found no significant association between overweight BMI and sexual dysfunction, with an odds ratio of 1.00 and a 95 percent confidence interval of 0.81 to 1.24. In other words, the pooled data could not distinguish women with overweight BMI from those with lower BMI in terms of sexual dysfunction risk.

The authors concluded that although most studies report a negative association between higher BMI and reduced sexual function in postmenopausal women, the meta-analysis, based on a limited number of eligible studies, did not show a significant pooled effect. They noted that elevated BMI is frequently correlated with poorer sexual function but that the current evidence is insufficient to support BMI as an independent causal factor, and they called for additional high-quality longitudinal studies to clarify the nature and direction of the relationship.

For clinicians and researchers, the review highlights both a signal and a gap. The authors’ note that the published version is still subject to further editorial updates, as the article was released early as a citable accepted manuscript with a permanent DOI.

Subject of Research: The relationship between body mass index and sexual function in postmenopausal women

Article Title: The relationship between sexual function and body mass index in postmenopausal women: a systematic review and meta-analysis

Article References: Nazarpour, S., Simbar, M., Kiani, Z., & Taherian, R. (2026). The relationship between sexual function and body mass index in postmenopausal women: a systematic review and meta-analysis. European Journal of Medical Research. https://doi.org/10.1186/s40001-026-05389-3

Image Credits: AI Generated

DOI: 10.1186/s40001-026-05389-3

Keywords: postmenopausal women, body mass index, sexual function, female sexual dysfunction, systematic review, meta-analysis, obesity, FSFI questionnaire, observational studies, quality of life, relationship, between

News Source: Ophelia Keating. (October 28, 2026). Higher BMI Linked to Poorer Sexual Function in Postmenopausal Women, but Pooled Evidence Remains Weak. Scienmag.

Tags: betweenbody-mass indexfemale sexual dysfunctionFSFI questionnaireMeta-analysisobesityobservational studiesPostmenopausal WomenQuality of Liferelationshipsexual functionsystematic review
Share12Tweet7Share2ShareShareShare1

Related Posts

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

October 28, 2026
Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

October 28, 2026

FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

October 28, 2026

Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

October 28, 2026

POPULAR NEWS

  • Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    29 shares
    Share 12 Tweet 7
  • Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

    29 shares
    Share 12 Tweet 7
  • FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

    29 shares
    Share 12 Tweet 7
  • Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.